Infectious Diseases

A new report, from the world’s leading epidemic modeling group at Imperial College London, is suggesting intensive active suppression may be the best intervention to reduce mortality and healthcare demand as the COVID-19 pandemic continues to spread.

Striking new findings have demonstrated how all variants of virus that causes COVID-19 can spread into the brain and travel from neuron to neuron. This indicates losing one's sense of smell is not necessarily linked to the virus infiltrating the brain.

Researchers at MIT's Lincoln Laboratory have designed a broad-spectrum antiviral drug that has so far proven effective against all 15 viruses it has been tested on.

An antiviral targeting the dengue virus was quietly abandoned by industry, but it's now suddenly back in the spotlight. A new study suggests it didn’t just slow the dengue virus, it blocked viral replication and reduced infection rates at high doses.

Researchers have developed a groundbreaking vaccine that generates immunity against the Epstein-Barr virus, a virus that almost all of us carry and which has been found to be a primary cause of diseases like multiple sclerosis and some cancers.

A study is offering the first genomic analysis of the virus behind the current wave of monkeypox. The research indicates it has rapidly generated an unusually high volume of mutations that could be associated with increased human-to-human transmission.